Fiche société
Trevena Inc.
Traitements, essais et publications liés.
Traitements5programmes
Essais1liés
Publications5liées
SourceDBlocale
Traitements
5| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| Part A: TRV250-20mg/mlA trial to assess the efficacy, safety, tolerability and effect of a drug (code name TRV250) given as an injection to subjects who have received an injection of a drug called glyceryl trinitrate (GTN) which is clinically known to induce an immediate headache of short duration (under 30 minutes), known as the "GTN immediate headache" | Migraine | Phase 1 | À vérifier | United Kingdom | À vérifier |
| Part B: TRV250 Dose 1A trial to assess the efficacy, safety, tolerability and effect of a drug (code name TRV250) given as an injection to subjects who have received an injection of a drug called glyceryl trinitrate (GTN) which is clinically known to induce an immediate headache of short duration (under 30 minutes), known as the "GTN immediate headache" | Migraine | Phase 1 | À vérifier | United Kingdom | À vérifier |
| Part B: TRV250 Dose 2A trial to assess the efficacy, safety, tolerability and effect of a drug (code name TRV250) given as an injection to subjects who have received an injection of a drug called glyceryl trinitrate (GTN) which is clinically known to induce an immediate headache of short duration (under 30 minutes), known as the "GTN immediate headache" | Migraine | Phase 1 | À vérifier | United Kingdom | À vérifier |
| Part B: TRV250 Dose 3A trial to assess the efficacy, safety, tolerability and effect of a drug (code name TRV250) given as an injection to subjects who have received an injection of a drug called glyceryl trinitrate (GTN) which is clinically known to induce an immediate headache of short duration (under 30 minutes), known as the "GTN immediate headache" | Migraine | Phase 1 | À vérifier | United Kingdom | À vérifier |
| Part A: TRV250-20mg/mlA trial to assess the efficacy, safety, tolerability and effect of a drug (code name TRV250) given as an injection to subjects who have received an injection of a drug called glyceryl trinitrate (GTN) which is clinically known to induce an immediate headache of short duration (under 30 minutes), known as the "GTN immediate headache" | Migraine | Phase 1 | À vérifier | United Kingdom | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Part A: TRV250-20mg/ml | Migraine | Phase 1 | NCT04201080 | A Trial to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous TRV250 | TERMINATED |
Publications
5| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Part A: TRV250-20mg/ml | Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure. | Archives of cardiovascular diseases | ||
| Part A: TRV250-20mg/ml | Socioeconomic factors and mortality in diastolic heart failure. | European journal of clinical investigation | ||
| Part B: TRV250 Dose 1 | A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects. | CNS drugs | ||
| Part A: TRV250-20mg/ml | Outbreak of hepatitis A infection associated with the consumption of frozen berries, Ireland, 2013--linked to an international outbreak. | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | ||
| Part A: TRV250-20mg/ml | Investigation of a foodborne outbreak of Shigella sonnei in Ireland and Northern Ireland, December 2016: the benefits of cross-border collaboration and commercial sales data. | Public health |